Consensus on early detection of disease progression in patients with multiple sclerosis

Autor: Meca-Lallana, José E, Casanova, Bonaventura, Rodríguez-Antigüedad, Alfredo, Eichau, Sara, Izquierdo, Guillermo, Durán, Carmen, Río, Jordi, Hernández, Miguel Ángel, Calles, Carmen, Prieto-González, José M, Ara, José Ramón, Uría, Dionisio F, Costa-Frossard, Lucienne, García-Merino, Antonio, Oreja-Guevara, Celia

Publikováno v: Frontiers in neurology
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Scientia

Consensus; Early detection; Secondary progressive multiple sclerosis Consenso; Detección precoz; Esclerosis múltiple progresiva secundaria Consens; Detecció precoç; Esclerosi múltiple progressiva secundària Background: Early identification of t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::125b7597254ad2d2ee30ddb5a4961f86

Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)

Autor: Jorge Aparicio, Anna C. Virgili Manrique, Jaume Capdevila, Félix Muñoz Boza, Patricia Galván, Paula Richart, Helena Oliveres, David Páez, Jorge Hernando, Sara Serrano, Ruth Vera, Xavier Hernandez-Yagüe, Rafael Álvarez Gallego, M. Carmen Riesco-Martinez, Xavier García de Albeniz, Joan Maurel

Publikováno v: CLINICAL & TRANSLATIONAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Clinical & Translational Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Scientia

Purpose Panitumumab plus FOLFOX (P-FOLFOX) is standard first-line treatment for RAS wild-type (WT) metastatic colorectal cancer. The value of panitumumab rechallenge is currently unknown. We assessed addition of panitumumab to FOLFIRI (P-FOLFIRI) bey

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::460d103a005870a3523482ea3189ad08
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16928

Predictors of Loss of Functional Independence in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up and Comparison with a Control Group

Autor: García, Diego Santos, Fonticoba, Teresa de Deus, Bartolomé, Carlos Cores, Ríos, Lucía Naya, Roca, Lucía García, Miró, Cristina Martínez, Canfield, Hector, Jesús, Silvia, Aguilar, Miquel, Pastor, Pau, Cosgaya, Marina, Caldentey, Juan García, Caballol, Nuria, Legarda, Inés, Vara, Jorge Hernández, Cabo, Iria, Manzanares, Lydia López, Aramburu, Isabel González, Rivera, María A. Ávila, Mayordomo, Víctor Gómez, Nogueira, Víctor, Puente, Víctor, Dotor, Julio, Borrué, Carmen, Vila, Berta Solano, Sauco, María Álvarez, Vela, Lydia, Escalante, Sonia, Cubo, Esther, Padilla, Francisco Carrillo, Castrillo, Juan C. Martínez, Alonso, Pilar Sánchez, Losada, Maria G. Alonso, Ariztegui, Nuria López, Gastón, Itziar, Kulisevsky, Jaime, Estrada, Marta Blázquez, Seijo, Manuel, Martínez, Javier Rúiz, Valero, Caridad, Kurtis, Mónica, Fábregues, Oriol de, Ardura, Jessica González, Redondo, Ruben Alonso, Ordás, Carlos, Díaz, Luis M. López, McAfee, Darrian, Martinez-Martin, Pablo, Mir, Pablo, Group, COPPADIS Study Group COPPADIS Study

Publikováno v: Scientia
Diagnostics
Volume 11
Issue 10
DIAGNOSTICS
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Diagnostics, Vol 11, Iss 1801, p 1801 (2021)
Digital.CSIC. Repositorio Institucional del CSIC

Background and objective: The aim of this study was to compare the progression of independence in activities of daily living (ADL) in Parkinson’s disease (PD) patients versus a control group, as well as to identify predictors of disability progress

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15e16fc5d449021ccb7e06e7dfd4f1c0
https://hdl.handle.net/11351/7449

A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation

Autor: Sébastien Michel, Mustapha Najimi, Yelena Vainilovich, Virginie Barthel, Luc L. Lasser, Victor Vargas, Desislava Lyubomirova, Agustín Albillos, Etienne Sokal, Noelia Gordillo, Nathalie Clerget-Chossat, Frederik Nevens, Pierre-François Laterre, Lyudmil E. Haralampiev, Thierry Gustot, Ivaylo Stoykov

Publikováno v: JHEP Reports
JHEP Reports, 3 (4
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientia
JHEP Reports, Vol 3, Iss 4, Pp 100291-(2021)
JHEP Reports, Vol. 3, no. 4, p. 100291 [1-10] (2021)

Background & Aims: Human allogeneic liver-derived progenitor cells (HALPC, HepaStem®; Promethera Biosciences, Mont-Saint-Guibert, Belgium) are an advanced therapy medicinal product that could potentially alleviate systemic inflammation and ameliorat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af21f831201daccbe657298e10bc15d2
https://lirias.kuleuven.be/handle/123456789/677657

Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial

Autor: Jens Gottlieb, Geert M. Verleden, Michael Perchl, Christina Valtin, Alexander Vallee, Olivier Brugière, Carlos Bravo

Publikováno v: PLoS ONE, Vol 16, Iss 12, p e0260881 (2021)
PLoS ONE
Scientia

BackgroundChronic Lung Allograft Dysfunction (CLAD) is a major obstacle for long term survival after lung transplantation (LTx). Besides Bronchiolitis Obliterans Syndrome, two other phenotypes of CLAD, restrictive allograft syndrome (RAS) and mixed p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97b86d7d415e0af7803b2b63bb2febe5
https://doaj.org/article/57e508ad0a004d3ba9d68d5c6ec0e228